Department of Neurology, Peking University Third Hospital, Beijing, China.
Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Disorders, Beijing, China.
Front Immunol. 2023 Aug 16;14:1246768. doi: 10.3389/fimmu.2023.1246768. eCollection 2023.
Amyotrophic lateral sclerosis (ALS) is a chronic, progressive neurodegenerative disease characterized by the loss of motor neurons. Dysregulated peripheral immunity has been identified as a hallmark of ALS. Neutrophils, as the front-line responders of innate immunity, contribute to host defense through pathogen clearance. However, they can concurrently play a detrimental role in chronic inflammation. With the unveiling of novel functions of neutrophils in neurodegenerative diseases, it becomes essential to review our current understanding of neutrophils and to recognize the gap in our knowledge about their role in ALS. Thus, a detailed comprehension of the biological processes underlying neutrophil-induced pathogenesis in ALS may assist in identifying potential cell-based therapeutic strategies to delay disease progression.
肌萎缩侧索硬化症(ALS)是一种慢性、进行性神经退行性疾病,其特征是运动神经元的丧失。失调的外周免疫已被确定为 ALS 的标志。中性粒细胞作为先天免疫的一线反应者,通过清除病原体来帮助宿主防御。然而,它们也可以在慢性炎症中发挥有害作用。随着中性粒细胞在神经退行性疾病中新型功能的揭示,有必要重新审视我们目前对中性粒细胞的认识,并认识到我们对其在 ALS 中的作用的认识存在差距。因此,详细了解中性粒细胞诱导 ALS 发病机制的生物学过程,可能有助于确定潜在的基于细胞的治疗策略来延缓疾病进展。